Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Compugen Ltd Azrieli Center 26 Harokmim Street Building D Holon L3 5885849 ISR

www.cgen.com Employees: 74 P: 972-3765-8585 F: 972-376-5855

Sector:

Medical

Description:

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.

Key Statistics

Overview:

Market Capitalization, $K 210,606
Enterprise Value, $K 192,376
Shares Outstanding, K 89,240
Float, K 80,762
% Float 90.50%
Short Interest, K 1,194
Short Float 0.00%
Days to Cover 2.52
Short Volume Ratio 0.46
% of Insider Shareholders 9.50%
% of Institutional Shareholders 12.22%

Financials:

Annual Sales, $ 27,860 K
Annual Net Income, $ -14,230 K
Last Quarter Sales, $ 1,890 K
Last Quarter Net Income, $ -6,980 K
EBIT, $ -32,200 K
EBITDA, $ -33,290 K

Growth:

1-Year Return -3.11%
3-Year Return 172.83%
5-Year Return -81.18%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 62.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/10/25
Next Earnings Date 03/03/26
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr 12.50%
EPS Growth vs. Prev Year -800.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -53.60%
Return-on-Assets % -25.41%
Profit Margin % -51.08%
Debt/Equity 0.00
Price/Sales 31.53
Price/Cash Flow N/A
Price/Book 4.81
Book Value/Share 0.49
Interest Coverage -0.03
60-Month Beta 2.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar